Bivalirudin edges unfractionated heparin for PCI in acute coronary syndrome patients …

posted in: Uncategorized | 0

SAN DIEGO– The antithrombin drug bivalirudin received a boost, compared with unfractionated heparin, as the safer drug for preventing ischemic events in patients with acute coronary syndrome undergoing percutaneous coronary intervention in results from …
a multicenter, randomized trial with more than 7,000 patients.

Leave a Reply